Lv11
70 积分 2025-01-25 加入
Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models
12小时前
已完结
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B cell lymphoma
6天前
已完结
Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
5个月前
已完结
Adaptable Leukemia Cells Resisting CAR T-cell Attack via B-cell Activation
5个月前
已完结
Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
5个月前
已完结
The present and future of CAR T-cell therapy for adult B-cell ALL
5个月前
已完结
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
5个月前
已完结
Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy
6个月前
已完结
皖公网安备34019202002308
